Connection

Michael Lilly to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Imatinib Mesylate.
Michael Lilly
Connection Strength
0.089
Imatinib Mesylate
  1. Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study. Am J Hematol. 2010 Mar; 85(3):164-70.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.